Related Experiment Video
Updated: Jul 3, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells
Luisa Cironi1, Nicolò Riggi, Paolo Provero
1Division of Experimental Pathology, Institute of Pathology CHUV, University of Lausanne, Lausanne, Switzerland.
Background:
The EWS-FLI-1 fusion protein is associated with 85-90% of Ewing's sarcoma family tumors (ESFT), the remaining 10-15% of cases expressing chimeric genes encoding EWS or FUS fused to one of several ets transcription factor family members, including ERG-1, FEV, ETV1 and ETV6. ESFT are dependent on insulin-like growth factor-1 (IGF-1) for growth and survival and recent evidence suggests that mesenchymal progenitor/stem cells constitute a candidate ESFT origin.
Methodology/Principal Findings:
To address the functional relatedness between ESFT-associated fusion proteins, we compared mouse progenitor cell (MPC) permissiveness for EWS-FLI-1, EWS-ERG and FUS-ERG expression and assessed the corresponding expression profile changes. Whereas all MPC isolates tested could stably express EWS-FLI-1, only some sustained stable EWS-ERG expression and none could express FUS-ERG for more than 3-5 days. Only 14% and 4% of the total number of genes that were respectively induced and repressed in MPCs by the three fusion proteins were shared. However, all three fusion proteins, but neither FLI-1 nor ERG-1 alone, activated the IGF1 promoter and induced IGF1 expression.
Conclusion/Significance:
Whereas expression of different ESFT-associated fusion proteins may require distinct cellular microenvironments and induce transcriptome changes of limited similarity, IGF1 induction may provide one common mechanism for their implication in ESFT pathogenesis.
Insights
Ewing
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ewing's sarcoma family tumors (ESFT) are primarily driven by EWS-FLI-1 fusion proteins, with other chimeric genes implicated in a minority of cases.
- ESFT growth and survival are critically dependent on insulin-like growth factor-1 (IGF-1).
- Mesenchymal progenitor/stem cells are a potential cell of origin for ESFT.
Purpose of the Study:
- To investigate the functional relationships among different ESFT-associated fusion proteins.
- To compare the ability of mouse progenitor cells (MPCs) to express various ESFT fusion proteins.
- To analyze the gene expression changes induced by these fusion proteins and identify common mechanisms in ESFT pathogenesis.
Main Methods:
- Assessed mouse progenitor cell (MPC) permissiveness for expressing EWS-FLI-1, EWS-ERG, and FUS-ERG fusion proteins.
- Analyzed gene expression profile changes in MPCs following expression of the fusion proteins.
- Investigated the activation of the IGF1 promoter and IGF1 expression by the fusion proteins.
Main Results:
- MPC isolates showed variable permissiveness for expressing EWS-FLI-1, EWS-ERG, and FUS-ERG.
- Transcriptome changes induced by the fusion proteins exhibited limited overlap.
- All three ESFT fusion proteins, but not FLI-1 or ERG-1 alone, activated the IGF1 promoter and induced IGF1 expression.
Conclusions:
- Different ESFT-associated fusion proteins may require distinct cellular environments and induce unique transcriptome alterations.
- IGF1 induction represents a potential common mechanism by which these fusion proteins contribute to ESFT development.
- Understanding these mechanisms can inform targeted therapeutic strategies for ESFT.
Related Concept Videos
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway

